IP Group plc - Employee Share Schemes; Director/PDMR shareholding
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces the following in connection with its employee share schemes.
Release of Deferred Bonus Awards
On 22 April 2026, the Group's executive directors and one other person discharging managerial responsibilities ("PDMR") received a total of 168,957 ordinary shares of two pence each ("Shares"), resulting from the release of Deferred Bonus Awards granted in relation to the partial deferral of annual bonuses for the 2023 and 2024 financial years.
The delivery of the awards was satisfied through the transfer of Shares from the Company's employee benefit trust (the "EBT"), with the balance being settled by cash payments in an amount sufficient to meet the relevant individuals' income and other tax liabilities in accordance with the rules of the IP Group Share Plan ("Share Plan").
The Shares transferred to the Group's executive directors will be held by the EBT on behalf of, and as nominee for, the executive directors in order to facilitate the application of the Group's Post Cessation Shareholding Policy.
A copy of the Share Plan can be found at:
https://www.ipgroupplc.com/investors/corporate-governance
Shares in issue
As at 22 April, the Company had 883,427,642 Shares in issue and no Shares held in treasury.
The following information is being disclosed pursuant to the requirements of MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
DBA Release
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Greg Smith David Baynes Mark Reilly
2
Reason for the notification
a)
Position/status
Director Chief Executive Officer Director Chief Operating and Financial Officer PDMR Managing Partner
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
IP Group plc
b)
Legal Entity Identifier
213800HG22UM138WFG43
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Ordinary Shares of 2p each in IP Group plc
ISIN: GB00B128J450
b)
Nature of the transaction
Release of the 2024 Deferred Bonus Awards and 2025 Deferred Bonus Awards
c)
Currency
GBP
d)
Price(s) and volume(s)
Name(s)
Price(s)
Volume(s)
Greg Smith
Conditional Share Award
67,116
David Baynes
Conditional Share Award
41,435
Mark Reilly
Conditional Share Award
60,406
e)
Aggregated information -Aggregated volume - Price - Aggregated total
168,957 63.7p £107,625.61
f)
Date of the transaction
22 April 2026
g)
Place of the transaction
London Stock Exchange, Main Market
For more information, please contact:
IP Group plc
www.ipgroupplc.com
Liz Vaughan-Adams, Communications Portland Alex Donaldson
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world's most exciting businesses in healthtech, deeptech and cleantech. Including through Parkwalk, the UK's largest growth EIS fund manager, we back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHPPUAGCUPQGGW
